Anterogen.Co.,Ltd. (KOSDAQ: A065660)
Health Care · Biotechnology · KR
₩16,190.00
+7.65% today · -34.3% 1Y
Anterogen.Co.,Ltd. (KOSDAQ: A065660) operates in the Biotechnology industry within the Health Care sector. The company is valued at $120.50M.
Over the last twelve months the share price has lost 34.3%, trading between 13.50K and 61.80K.
Tweenvest scores Anterogen.Co.,Ltd. across four factors: quality 76/100, value 67/100. Its strongest factor is quality.
A065660 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $120.50M
- Revenue (TTM)
- $5.40M
- P/E
- —
- EPS
- -161.85
- Dividend yield
- —
- Beta (5Y)
- -0.15
- 52-week high
- ₩61,800.00
- 52-week low
- ₩13,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.01M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cereno Scientific AB (publ)OM: CRNO B | $123.72M | Skr3.82 | -5.59% |
| BRIM Biotechnology, Inc.TWSE: 6885 | $123.18M | NT$29.60 | -2.63% |
| Kazia Therapeutics LimitedNasdaqCM: KZIA | $122.37M | $8.08 | -9.52% |
| ISU Abxis Co., Ltd.KOSDAQ: A086890 | $120.71M | ₩3,980.00 | +3.51% |
| Foghorn Therapeutics Inc.NasdaqGM: FHTX | $118.77M | $1.90 | -5.00% |
| Cibus, Inc.NasdaqCM: CBUS | $118.46M | $1.43 | -7.74% |
| Nykode Therapeutics ASOB: NYKD | $117.42M | Nkr3.20 | -6.98% |
| Oncopeptides AB (publ)OM: ONCO | $117.17M | Skr2.96 | +40.74% |
Figures last refreshed Oct 11, 2026.